Table 2.

Baseline demographic characteristics of the study groups and in the total sample of the study (e.g., race, smoking, history of the disease, comorbidities)

Index		Group						Total
		DIM		DIM		Placebo
		100 mg/day		200 mg/day
		Rate	% in group	Rate	% in group	Rate	% in group	Rate	% of all
Race	Caucasian	24	100	23	100	23	100	70	100
	Other	0	0	0	0	0	0	0	0
Smoking	No	23	92	24	100	23	92	70	94.6
	Yes	2	8	0	0	2	8	4	5.4
Significant diseases in anamnesis	No	20	87.0	18	78.3	19	82.6	57	82.6
	Yes	3	13.0	5	21.7	4	17.4	12	17.4
The presence of comorbidities	No	18	78.3	17	74.0	20	87.0	55	79.7
	Yes	5	21.7	6	26.0	3	13.0	14	20.3

DIM 3,3′-diindolylmethane